Preclinical studies show that inhibition of PI3K signaling or CDK4/6 can sensitize tumor cells to ionizing radiation by impairing DNA damage repair processes and altering cell-cycle distribution, thereby increasing persistent DNA damage and radiosensitivity (70, 71). This evidence concerns the gene CDK4 and neoplasm.